[go: up one dir, main page]

MX2016000006A - Sales de nalmefeno como medicamentos para reducir el consumo de alcohol o para prevenir el consumo excesivo de alcohol. - Google Patents

Sales de nalmefeno como medicamentos para reducir el consumo de alcohol o para prevenir el consumo excesivo de alcohol.

Info

Publication number
MX2016000006A
MX2016000006A MX2016000006A MX2016000006A MX2016000006A MX 2016000006 A MX2016000006 A MX 2016000006A MX 2016000006 A MX2016000006 A MX 2016000006A MX 2016000006 A MX2016000006 A MX 2016000006A MX 2016000006 A MX2016000006 A MX 2016000006A
Authority
MX
Mexico
Prior art keywords
salt
alcohol consumption
salts
hydrogen
medicaments
Prior art date
Application number
MX2016000006A
Other languages
English (en)
Inventor
Heidi Lopez De Diego
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of MX2016000006A publication Critical patent/MX2016000006A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08Oxygen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Emergency Medicine (AREA)
  • Steroid Compounds (AREA)

Abstract

La presente invención se refiere a nuevas sales de nalmefeno las cuales pertenecen a al menos a una de las dos categorías siguientes: sales que no forman hidratos y sales que no forman solvatos. En particular, la invención se refiere a la sal hidrogenoadipato, la sal hidrogenomalonato, la sal lactato, la sal hidrogenofumarato, la sal hidrogenosuccinato, la sal bencenosulfonato, la sal hidrogenomaleato y la sal salicilato de nalmefeno. La presente invención también se refiere a tales sales para su uso en terapia.
MX2016000006A 2013-07-11 2014-07-10 Sales de nalmefeno como medicamentos para reducir el consumo de alcohol o para prevenir el consumo excesivo de alcohol. MX2016000006A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201300421 2013-07-11
PCT/EP2014/064819 WO2015004240A1 (en) 2013-07-11 2014-07-10 Nalmefene salts as medicaments for reducing alcohol consumption or for preventing excessive alcohol consumption

Publications (1)

Publication Number Publication Date
MX2016000006A true MX2016000006A (es) 2016-03-09

Family

ID=51177066

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016000006A MX2016000006A (es) 2013-07-11 2014-07-10 Sales de nalmefeno como medicamentos para reducir el consumo de alcohol o para prevenir el consumo excesivo de alcohol.

Country Status (28)

Country Link
US (2) US9725458B2 (es)
EP (1) EP3019500B1 (es)
JP (1) JP6491653B2 (es)
KR (1) KR20160030130A (es)
CN (1) CN105377854B (es)
AR (1) AR096851A1 (es)
AU (1) AU2014289182B2 (es)
CA (1) CA2917576C (es)
CL (1) CL2015003736A1 (es)
CY (1) CY1122099T1 (es)
DK (1) DK3019500T3 (es)
EA (1) EA031747B1 (es)
ES (1) ES2749614T3 (es)
HR (1) HRP20191764T1 (es)
HU (1) HUE046904T2 (es)
IL (1) IL243243B (es)
LT (1) LT3019500T (es)
ME (1) ME03504B (es)
MX (1) MX2016000006A (es)
PH (1) PH12016500052A1 (es)
PL (1) PL3019500T3 (es)
PT (1) PT3019500T (es)
RS (1) RS59349B1 (es)
SG (1) SG11201600116VA (es)
SI (1) SI3019500T1 (es)
SM (1) SMT201900558T1 (es)
TW (1) TW201536288A (es)
WO (1) WO2015004240A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR096851A1 (es) 2013-07-11 2016-02-03 H Lundbeck As Sales que no forman hidratos ni solvatos de nalmefeno
US20220280494A1 (en) * 2019-08-28 2022-09-08 Delpor, Inc. Compositions for small molecule therapeutic agent compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU196376B (en) * 1985-05-23 1988-11-28 Sandoz Ag Process for preparing morphinane derivatives and pharmaceutical compositions containing such compounds
US20030153590A1 (en) 2001-08-14 2003-08-14 Oy Contral Pharma Ltd Method of treating alcoholism or alcohol abuse
PL2307420T3 (pl) * 2008-04-24 2012-04-30 Janssen Pharmaceutica Nv Proleki diestrowe nalmefenu
GB0814043D0 (en) * 2008-07-31 2008-09-10 Serentis Ltd The treatment of skin disorders
UA102128C2 (en) 2008-12-05 2013-06-10 Х. Луннбек А/С Nalmefene hydrochloride dihydrate
EA019331B1 (ru) 2009-05-25 2014-02-28 Х. Лундбекк А/С Получение налмефена гидрохлорида из налтрексона
MX2013005009A (es) 2010-11-05 2013-08-01 Lundbeck & Co As H Metodo para la elaboracion de naltrexona.
CN103012416B (zh) 2011-09-28 2015-07-01 辽宁海思科制药有限公司 一种盐酸纳美芬的制备方法
AR096851A1 (es) 2013-07-11 2016-02-03 H Lundbeck As Sales que no forman hidratos ni solvatos de nalmefeno

Also Published As

Publication number Publication date
HUE046904T2 (hu) 2020-03-30
AU2014289182A1 (en) 2016-01-21
CA2917576C (en) 2022-05-31
PH12016500052B1 (en) 2016-03-28
US20170275294A1 (en) 2017-09-28
DK3019500T3 (da) 2019-10-14
EP3019500A1 (en) 2016-05-18
SI3019500T1 (sl) 2019-11-29
US9938286B2 (en) 2018-04-10
SG11201600116VA (en) 2016-02-26
IL243243B (en) 2018-12-31
WO2015004240A1 (en) 2015-01-15
CL2015003736A1 (es) 2016-08-19
LT3019500T (lt) 2019-10-25
SMT201900558T1 (it) 2019-11-13
CA2917576A1 (en) 2015-01-15
EA031747B1 (ru) 2019-02-28
AR096851A1 (es) 2016-02-03
EA201592228A1 (ru) 2016-05-31
TW201536288A (zh) 2015-10-01
PL3019500T3 (pl) 2020-01-31
JP2016523949A (ja) 2016-08-12
AU2014289182B2 (en) 2018-02-22
CY1122099T1 (el) 2020-11-25
US9725458B2 (en) 2017-08-08
CN105377854B (zh) 2018-08-31
HRP20191764T1 (hr) 2019-12-27
PT3019500T (pt) 2019-10-25
CN105377854A (zh) 2016-03-02
JP6491653B2 (ja) 2019-03-27
EP3019500B1 (en) 2019-09-11
KR20160030130A (ko) 2016-03-16
ES2749614T3 (es) 2020-03-23
RS59349B1 (sr) 2019-10-31
PH12016500052A1 (en) 2016-03-28
NZ715200A (en) 2021-02-26
ME03504B (me) 2020-04-20
US20160152625A1 (en) 2016-06-02

Similar Documents

Publication Publication Date Title
JO3343B1 (ar) أحماض 5- أمينوتتراهيدروكوينولين-2- كربوكسيليك جديدة واستخدامها
AU344107S (en) Universal pillow
PH12014502496A1 (en) Bicyclically substituted uracils and the use thereof
MX2016005760A (es) Inhibidores de glucogeno sintasa cinasa 3 (gsk-3).
MX2019008643A (es) Uso de serlopitant como antagonistas del receptor nk-1 en prurito.
CR20160136A (es) Compuestos heterocíclicos
PH12015502118A1 (en) Pyridin-4-yl derivatives
PH12015501054A1 (en) Pyridiyloxyalkyl carboxamides and use thereof as endoparasiticides and nematicides
MX2015012580A (es) El uso de sdf-1 para atenuar la formacion de cicatrices.
EA201492152A1 (ru) Налмефен для уменьшения потребления алкоголя у конкретных целевых популяций
PH12016500052A1 (en) Nalmefene salts as medicaments for reducing alcohol consumption or for preventing excessive alcohol consumption
MX356804B (es) Polimorfos de 2-(4-(2-(1-isopropil-3-metil-1h-1,2,4-triazol-5-il)- 5,6-dihidrobenzo[f]imidazol[1,2-d][1,4]oxazepin-9-il)-1h-pirazol- 1-il)-2-metilpropanamida, metodos de produccion, y usos farmaceuticos de los mismos.
PH12014500577A1 (en) Sulfonic acid salts of heterocyclylamide-substituted imidazoles
MX362686B (es) Inmunógenos fúngicos y materiales y métodos relacionados.
UY34564A (es) Utilización en terapéutica de derivados de imidazopiridina
MX2016002186A (es) Proceso para preparar dronedarona y sales de la misma.
TH168423A (th) เกลือของนาลมีฟีนในฐานะยาสำหรับการลดการบริโภคแอลกอฮอล์หรือสำหรับ การป้องกันการบริโภคแอลกอฮอล์มากเกินไป
IGUCHI Recent Trends in Remote Sensing Research
HK1225015A1 (en) Nalmefene salts as medicaments for reducing alcohol consumption or for preventing excessive alcohol consumption
UA70225U (ru) Применение композиции, содержащей мирамистин, в качестве лекарственного средства для лечения заболеваний горла
TN2014000085A1 (en) Substituted annellated pyrimidine and the use thereof
UA70542U (ru) Способ психофармакотерапии компьютерной зависимости
UA85573U (ru) Способ нивелирования стресс-индуцированной гипергликемии при острых критических состояниях
UA83243U (uk) Спосіб введення активних речовин
UA79947U (ru) Применение 4-[4-оксо-(4H)-хиназолин-3-ил]бензойной кислоты в качестве средства с центральным обезболивающим действием